AU2020901025A0 - Antibiotic conjugates for enhanced clearance of bacterial infections - Google Patents

Antibiotic conjugates for enhanced clearance of bacterial infections

Info

Publication number
AU2020901025A0
AU2020901025A0 AU2020901025A AU2020901025A AU2020901025A0 AU 2020901025 A0 AU2020901025 A0 AU 2020901025A0 AU 2020901025 A AU2020901025 A AU 2020901025A AU 2020901025 A AU2020901025 A AU 2020901025A AU 2020901025 A0 AU2020901025 A0 AU 2020901025A0
Authority
AU
Australia
Prior art keywords
bacterial infections
enhanced clearance
antibiotic conjugates
conjugates
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020901025A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Original Assignee
Monash University
Filing date
Publication date
Application filed by Monash University filed Critical Monash University
Publication of AU2020901025A0 publication Critical patent/AU2020901025A0/en
Priority to PCT/AU2021/050306 priority Critical patent/WO2021195716A1/en
Pending legal-status Critical Current

Links

AU2020901025A 2020-04-02 2020-04-02 Antibiotic conjugates for enhanced clearance of bacterial infections Pending AU2020901025A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2021/050306 WO2021195716A1 (en) 2020-04-02 2021-04-01 Antibiotic conjugates

Publications (1)

Publication Number Publication Date
AU2020901025A0 true AU2020901025A0 (en) 2020-04-23

Family

ID=

Similar Documents

Publication Publication Date Title
WO2020061375A8 (en) Antibacterial compounds
EP3846616A4 (en) Cannabinoids for the treatment of gram-positive infections including antibiotic-resistant bacterial strains
WO2011019839A3 (en) Glycopeptide and lipoglycopeptide antibiotics with improved solubility
IL290260A (en) Orally administered combinations of beta-lactam antibiotics and avibactam derivatives for treating bacterial infections
AU2020901025A0 (en) Antibiotic conjugates for enhanced clearance of bacterial infections
EP3965794A4 (en) Antibiotic cannabinoid-terpene formulations
EP4095141A4 (en) Cephalosporin antibacterial compound and pharmaceutical application thereof
EP4165815A4 (en) Channel access scheme enhancements
AU2021901604A0 (en) Treatment of bacterial infections
AU2023901728A0 (en) Treatment of bacterial infections
AU2022901468A0 (en) Treatment of bacterial infections
AU2021901973A0 (en) Antibiotic Compounds
EP3979833A4 (en) System and method for combating plant pathogenic bacterial infections
AU2020902636A0 (en) Compositions and methods for treating bacterial infections
EP4028404A4 (en) Penam derivatives for treating bacterial infections
AU2023903533A0 (en) Flavonoid composition
AU2023903253A0 (en) Convey AI
AU2022421489A1 (en) A pharmaceutical composition for the treatment of otic infections
AU2022902157A0 (en) Antibacterial Compound
GB202207185D0 (en) Novel antibiotic compound
AU2022900343A0 (en) Compositions and methods for treating infections
TW202417437A (en) Antibacterial compounds
TW202417432A (en) Antibacterial compounds
AU2020901983A0 (en) Treatment for fungal infections
GB202118038D0 (en) Universal antibiotic